News
Sallie Mae (NASDAQ: SLM) has announced the appointment of two new members to its board of directors, effective April 23, 2025 ...
Summit Therapeutics Inc. is currently enrolling patients in the Harmoni-7 study, a multiregional Phase III clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback